Browsing Tag
gene editing
6 posts
Why YolTech Therapeutics believes YOLT-202 could become a “one-and-done” treatment for Alpha-1 Antitrypsin Deficiency
YolTech Therapeutics receives FDA clearance to launch a Phase 2/3 trial of YOLT-202 for Alpha-1 Antitrypsin Deficiency. Discover what this means for gene editing.
Precision BioSciences $75m stock and warrant offering sparks debate over biotech funding momentum
Precision BioSciences completes a $75 million stock and warrant offering to fund its ARCUS gene-editing pipeline — find out how this move reflects broader biotech funding trends.
How CRISPR Therapeutics’ one-and-done CTX310 therapy could transform treatment for high cholesterol and triglycerides
Find out how CRISPR Therapeutics’ CTX310 gene-editing therapy achieved profound cholesterol and triglyceride reductions — could it reshape cardiovascular care?
Caribou Biosciences set for key webcast showcasing CRISPR-engineered CAR-T breakthroughs in blood cancers
Discover how Caribou Biosciences is preparing to reveal breakthrough CRISPR-edited allogeneic CAR-T data in lymphoma and myeloma during its investor webcast.
Base editing 101: Is precision gene editing safer than CRISPR‑Cas9 for therapeutic use?
Is base editing safer than CRISPR? See how Beam, Verve, and Prime are using non-cutting gene editing to raise the bar for precision and clinical safety.
Precision BioSciences gets FDA clearance for ELIMINATE-B trial of PBGENE-HBV
Precision BioSciences has secured a major regulatory breakthrough as the U.S. Food and Drug Administration (FDA) granted clearance…